Application for permit to import Controlled Substances DEA Form 357
DEA Form 357 - Application for Permit to Import Controlled Substances for Domestic and/or Scientific Purposes (PDF)
INFORMATION AND INSTRUCTIONS, DEA FORM 357
https://www.deadiversion.usdoj.gov/imp_exp/357/form-357.html
MJ will be added to the registration form soon…that, NAFTA and also the power of Big Pharma, Tilray will dominate the US prescription weed market after rescheduling.
The DEA has been dragging their feet since the FDA recommended to them that marijuana be reclassified to schedule 3 last summer.
But when the Vice President OTUS TELLS you to “act as quickly as possible” you’re gonna need to do just that…
Last months closed door meeting at the White House most likely drastically sped up the DEA's decision and announcement for rescheduling…
Vice President Kamala Harris, who convened the meeting, shared an opening statement (which was broadcast publicly) in which she called on the U.S. Drug Enforcement Administration (DEA) to act “as quickly as possible” on cannabis’s scheduling review and said cannabis’s Schedule I classification under the Controlled Substances Act is “absurd and patently unfair,”
But following the vice president’s opening statement, media attendees were asked to leave, and the remainder of the meeting took place behind closed doors.
https://www.cannabisbusinesstimes.com/news/vp-kamala-harris-we-need-to-legalize-marijuana-in-closed-door-meeting-interview-chris-goldstein/
And late last week (Thursday) in a congressional hearing the FDA Head Says There’s ‘No Reason For DEA To Delay’ Rescheduling Marijuana
https://www.marijuanamoment.net/watch-live-fda-commissioner-testifies-on-hemp-regulatory-issues-at-congressional-hearing/
DEA has all they need already:
FDA Releases Its Scientific Support for Rescheduling Marijuana to Schedule III
January 18th 2024
https://www.mcguirewoods.com/client-resources/alerts/2024/1/fda-releases-its-scientific-support-for-rescheduling-marijuana-to-schedule-iii/
Marijuana meets criteria for reclassification as lower-risk drug, FDA scientific review finds
January 12th 2024
https://amp.cnn.com/cnn/2024/01/12/health/marijuana-rescheduling-fda-review
One more thing, tomorrow could be Tax Relief Tuesday for Tilray after a parliamentary finance committee proposed capping excise taxes at 10% of the value of a marijuana product.
Simon said Tilray would save $80 million annually if that recommendation were implemented.
Feds here in Canada need to support what they started and not let the weed industry keep suffering and this is one simple measure that will be a huge positive for this industry when it needs it the most!
Cheers, have a great week )